Welcome to our dedicated page for Medigus Ltd. American Depositary Share news (Ticker: MDGS), a resource for investors and traders seeking the latest updates and insights on Medigus Ltd. American Depositary Share stock.
Medigus Ltd. (MDGS) pioneers minimally invasive endoscopic solutions for gastrointestinal disorders, with its flagship SRS system transforming GERD treatment. This dedicated news hub provides investors and medical professionals with timely updates on the company’s technological advancements, regulatory milestones, and strategic partnerships.
Access comprehensive coverage of Medigus’ developments including product launches, clinical trial results, financial performance, and OEM manufacturing initiatives. Our curated repository ensures stakeholders stay informed about innovations in endoscopic stapling systems, ultrasonic alignment technologies, and collaborative healthcare projects.
Key updates feature progress in endoluminal procedures, manufacturing expansions, and intellectual property achievements. Regular updates include earnings reports, executive leadership changes, and research breakthroughs that underscore Medigus’ position in medical device innovation.
Bookmark this page for direct access to official press releases and objective analysis of Medigus’ contributions to minimally invasive surgery. Check regularly for verified updates on the company’s progress in redefining endoscopic intervention standards and expanding global healthcare partnerships.
Medigus Ltd. (Nasdaq:MDGS) has announced that Smart Repair Pro, a data-driven e-commerce company, has completed all regulatory processes required by Amazon, enabling its store launch in Australia. This marks Smart Repair Pro's entry into the Australian market, following approvals to launch in five European countries and current operations in the U.S. Medigus is acquiring a controlling interest in Smart Repair Pro and Purex, owning 50.01% of both. The companies aim for 2020 revenues of approximately $3 million, with a net profit margin of around 35%.
Medigus Ltd. (Nasdaq:MDGS) announced a strategic investment in Eventer Technologies Ltd., acquiring a 50.1% stake with an investment of up to $1 million and a loan of $1.25 million. Eventer, a platform for automated ticketing and event management, has hosted 22,700 events, reflecting a 118% annual growth. The company aims to expand its reach, particularly in North America, capitalizing on increased demand for online events. With a commission structure of 3%-6% on ticket sales, Eventer generated approximately NIS 88 million in ticket sales in 2019.
Medigus Ltd. (NASDAQ:MDGS) has increased its stake in Gix Internet Ltd. to approximately 33%, becoming its largest shareholder. Gix Internet reported revenues of $18.5 million for Q2 2020, with a market cap of $10 million as of October 14, 2020. This move allows Medigus to convert Linkury Shares into Ordinary Shares of Gix Internet, totaling around 9.86 million shares, pending shareholder approval. The company's technology is integrated with major platforms including Google and Apple.
On October 13, 2020, Medigus Ltd. (NASDAQ:MDGS) announced the completion of Amazon's regulatory processes allowing its subsidiary Smart Repair Pro, Inc. to launch an e-commerce store in the UK, France, Italy, Germany, and Spain. This follows Medigus's recent acquisition of a controlling interest in Smart Repair Pro and Purex, Inc., targeting approximately $3 million in revenue for 2020 with a net profit margin of 35%. The closing of the deal is subject to customary conditions.
Medigus Ltd. (NASDAQ:MDGS) has signed a definitive agreement to acquire a controlling interest in Smart Repair Pro, Inc. and Purex, Inc., both e-commerce companies on Amazon Marketplace. Medigus will invest $1,250,000, pay $150,000 in cash, and issue $500,000 in restricted ADSs, with the potential for additional milestone payments of $750,000. The companies aim for a revenue of approximately $3 million in 2020, with a net profit margin of about 35%. The deal is subject to customary closing conditions.
Medigus Ltd. (NASDAQ:MDGS) announces its subsidiary ScoutCam Inc. has upgraded to the OTCQB Venture Market, enhancing its visibility within the investment community. ScoutCam, specializing in custom visual solutions including micro-cameras, aims to leverage this upgrade to attract more investors. The OTCQB provides high-quality trading for entrepreneurial companies and requires compliance with financial reporting and other eligibility criteria. This upgrade marks a significant milestone for ScoutCam, furthering its market position.
Medigus Ltd. (NASDAQ: MDGS) announced that its subsidiary, ScoutCam, has been included on a Fortune 500 healthcare corporation’s Approved Supplier List (ASL). This designation enables ScoutCam to provide complete visualization solutions using its miniature video cameras for minimally invasive surgical products. A contract is expected to yield development fees of $2.4 million over 2020-2021, alongside potential sales of tens of thousands of cameras annually. The partnership is anticipated to enhance surgical outcomes while adhering to strict quality standards.
Medigus Ltd. (NASDAQ: MDGS) reported its financial results for H1 2020, revealing an IFRS loss of $3.6 million and a non-IFRS net loss of $3 million, both significantly higher than the previous year. Revenues dropped 49% to $73,000, and general administrative expenses surged by 126% to $2.6 million. Despite these challenges, the company maintained cash and equivalents of $10.2 million. Noteworthy developments include investments in Matomy Media and ScoutCam, along with a reseller agreement for COVID-19 protective products, which could enhance future revenue streams.
Medigus has signed a non-binding letter of intent to acquire a controlling interest in Smart Repair Pro, Inc. and Purex, Inc., both operating on the Amazon Marketplace. The investment involves a total of $1,250,000 in cash and restricted shares, aiming for Medigus to hold 50.01% in each company. With projected revenues of $3 million for 2020 and a net profit margin of 35%, this move marks Medigus' expansion into the e-commerce sector, complementing its existing medical operations.
Medigus Ltd. (NASDAQ: MDGS) announced that its subsidiary, ScoutCam Inc., has accepted a $2.4 million quote from a Fortune 500 healthcare corporation for single-use miniature video cameras. This partnership aims to develop a complete visualization solution for minimally invasive surgical procedures. The project, part of an ongoing Development Strategy Agreement initiated in November 2019, is expected to yield substantial revenue, with forecasts suggesting tens of thousands of camera sales annually. The collaboration highlights the growing demand for innovative medical technologies.